14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CLVS
Delisted

Clovis Oncology Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 20 May 2024

CLVS Predictions History

7 years ago
 Xabulon predicted that CLVS for 2016-08-31 is going $23.49 (-3.01%)

Rank:

7 years ago
 kevin predicted that CLVS for 2016-08-31 is going $23.84 (-1.57%)

Rank:

7 years ago
 JS predicted that CLVS for 2016-08-31 is going $25.21 (4.09%)

Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT